Certolizumab-induced guttate psoriasiform dermatitis.

Certolizumab-induced guttate psoriasiform dermatitis.
Dermatol Online J. 2017 Jan 15;23(1):
Authors: Fischer R, DaCunha M, Rajpara A
Abstract
Certolizumab is a TNF inhibitor that has showngreat efficacy in chronic inflammatory diseases. Wereport a patient exhibiting a novel adverse effect ofcertolizumab: drug-induced guttate psoriasiformeruption. A review of the mechanism of psoriasiformdrug eruptions is also included.
PMID: 28329474 [PubMed - in process]

Source: Dermatol Online J - January 15, 2017 Category: Dermatology Authors: Fischer R, DaCunha M, Rajpara A Tags: Dermatol Online J Source Type: research